# Nanoparticle for DSA Removal

> **NCT04277377** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Zurich** · enrollment: 100 (estimated)

## Conditions studied

- Kidney Failure
- Presence of Donor Specific Antibodies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04277377
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-05
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04277377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04277377, "Nanoparticle for DSA Removal". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04277377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*